Penumbra, Inc. Form 8-K Summary
Business Context and Reporting Period
Penumbra, Inc. (PEN), a medical device company incorporated in Delaware, filed this Current Report on Form 8-K on November 7, 2019. The filing announces financial results for the third fiscal quarter ended September 30, 2019.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K document.
Material Changes
The filing does not explicitly detail material changes versus the prior comparable period. It serves as a notification that results for the quarter ended September 30, 2019, have been issued.
Guidance, Outlook, and Risks
Management commentary, forward-looking guidance, specific risks, contingencies, and unusual items are not described in the text of this 8-K. The document states that the information is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, directing readers to the attached press release for full details.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 7, 2019) for specific Q3 2019 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check for any updated full-year 2019 guidance provided in the press release.
- Confirm the status of any material contracts or regulatory updates mentioned in the full press release.